PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $302,000 | -22.0% | 122,095 | -0.7% | 0.00% | 0.0% |
| Q3 2020 | $387,000 | +29.0% | 123,000 | +19.2% | 0.00% | 0.0% |
| Q2 2020 | $300,000 | +9.5% | 103,145 | +6.1% | 0.00% | 0.0% |
| Q1 2020 | $274,000 | +21.2% | 97,250 | +39.8% | 0.00% | 0.0% |
| Q4 2019 | $226,000 | +48.7% | 69,580 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $152,000 | -42.2% | 70,169 | -16.3% | 0.00% | 0.0% |
| Q2 2019 | $263,000 | -16.8% | 83,789 | -1.5% | 0.00% | 0.0% |
| Q1 2019 | $316,000 | +64.6% | 85,036 | +28.3% | 0.00% | 0.0% |
| Q4 2018 | $192,000 | -35.1% | 66,256 | -41.1% | 0.00% | 0.0% |
| Q3 2018 | $296,000 | -43.4% | 112,521 | -49.6% | 0.00% | -66.7% |
| Q2 2018 | $523,000 | -36.1% | 223,317 | -19.8% | 0.00% | -25.0% |
| Q1 2018 | $819,000 | +11.7% | 278,498 | +4.1% | 0.00% | 0.0% |
| Q4 2017 | $733,000 | -0.3% | 267,641 | +23.4% | 0.00% | 0.0% |
| Q3 2017 | $735,000 | +37.6% | 216,831 | +0.3% | 0.00% | +33.3% |
| Q2 2017 | $534,000 | -31.8% | 216,136 | -37.4% | 0.00% | -40.0% |
| Q1 2017 | $783,000 | +24.5% | 345,071 | +16.3% | 0.01% | 0.0% |
| Q4 2016 | $629,000 | -48.0% | 296,658 | -17.8% | 0.01% | -44.4% |
| Q3 2016 | $1,209,000 | +17.5% | 360,799 | +10.1% | 0.01% | +12.5% |
| Q2 2016 | $1,029,000 | -37.1% | 327,762 | -33.3% | 0.01% | -42.9% |
| Q1 2016 | $1,635,000 | +105.4% | 491,033 | +118.4% | 0.01% | +100.0% |
| Q4 2015 | $796,000 | -73.8% | 224,860 | -62.8% | 0.01% | -77.4% |
| Q3 2015 | $3,042,000 | -52.5% | 604,797 | -39.3% | 0.03% | -53.0% |
| Q2 2015 | $6,406,000 | +31.9% | 996,248 | +44.3% | 0.07% | +22.2% |
| Q1 2015 | $4,858,000 | +230.9% | 690,489 | +262.6% | 0.05% | +200.0% |
| Q4 2014 | $1,468,000 | -51.5% | 190,425 | -53.0% | 0.02% | -56.1% |
| Q3 2014 | $3,027,000 | +285.6% | 405,210 | +399.7% | 0.04% | +272.7% |
| Q2 2014 | $785,000 | +56.1% | 81,084 | +33.9% | 0.01% | +57.1% |
| Q1 2014 | $503,000 | -14.0% | 60,574 | -12.6% | 0.01% | -22.2% |
| Q4 2013 | $585,000 | +4.3% | 69,274 | -1.6% | 0.01% | -18.2% |
| Q3 2013 | $561,000 | +64.0% | 70,418 | +58.7% | 0.01% | +37.5% |
| Q2 2013 | $342,000 | – | 44,365 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |